[1]
MacConaill, L.E.; Garraway, L.A. Clinical implications of the cancer genome. J. Clin. Oncol., 2010, 28(35), 5219.
[3]
Mansoori, B.; Mohammadi, A.; Davudian, S.; Shirjang, S.; Baradaran, B. The different mechanisms of cancer drug resistance: a brief review. Adv. Pharma. Bull., 2017, 7(3), 339.
[4]
Kim, M.H.; Kim, S-H.; Yang, W.M. Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimerʼs disease. Planta Med., 2014, 80(15), 1249-1258.
[5]
Kim, H-J.; Kim, S-K.; Kim, B-S.; Lee, S-H.; Park, Y-S.; Park, B-K.; Kim, S-J.; Kim, J.; Choi, C.; Kim, J-S. Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J. Agric. Food Chem., 2010, 58(15), 8643-8650.
Current Drug Metabolism
Title:Challenges in the Discovery of Novel Therapeutic Agents in Cancer
Volume: 20 Issue: 13
Author(s): Ganji Purnachandra Nagaraju and Mohammad Amjad Kamal
Affiliation:
Export Options
About this article
Cite this article as:
Nagaraju Purnachandra Ganji and Kamal Amjad Mohammad , Challenges in the Discovery of Novel Therapeutic Agents in Cancer, Current Drug Metabolism 2019; 20 (13) . https://dx.doi.org/10.2174/138920022013200123122311
DOI https://dx.doi.org/10.2174/138920022013200123122311 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
27
4
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Update on the Rheumatologic Manifestations of Malignancy
Current Cancer Therapy Reviews Review of Airway Illnesses by Kytococcus and Rothia and a Look at Inhalatory Vancomycin as a Treatment Support
Recent Patents on Anti-Infective Drug Discovery Molecular Mechanisms of Liver Cancer
Anti-Cancer Agents in Medicinal Chemistry Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer Cells
Current Drug Targets Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue
Current Medicinal Chemistry Hedgehog Signaling and Urological Cancers
Current Drug Targets Dietary Habits of Mongolian People, and Their Influence on Lifestyle-Related Diseases and Early Aging
Current Aging Science The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on CD34+/CD38+ and CD34+/CD38- AML Progenitor Cells
Current Cancer Drug Targets Targeting Cancer: The Challenges and Successes of Structure-Based Drug Design Against the Human Purinome
Current Topics in Medicinal Chemistry Subject Index To Volume 7
Current Drug Metabolism Targeting the Hippo Pathway for Anti-cancer Therapies
Current Medicinal Chemistry Synergetic Bitherapy in Mice with Xenografts of Human Prostate Cancer Using a Methional Mimic (METLICO) and an Aldehyde Dehydrogenase 3 Inhibitor (MATE): Systemic Intraperitoneal (IP) and Targeted Intra-Tumoral (IT) Administration
Current Medicinal Chemistry IO Nation: The Rise of Immuno-Oncology
Current Pharmacogenomics and Personalized Medicine Rapid Characterization of a Novel Taspine Derivative-HMQ1611 Binding to EGFR by a Cell Membrane Chromatography Method
Combinatorial Chemistry & High Throughput Screening Apoptosis-Inducing Activity and Antiproliferative Effect of Gossypin on PC-3 Prostate Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Targeting Oncogenes and Tumor Suppressors genes to Mitigate Chemoresistance
Current Cancer Drug Targets Modulating Fatty Acid Metabolism and the AMP-Activated Protein Kinase Pathway as a Target for Obesity Therapy
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Between Bench and Bed Side: PI3K Inhibitors
Current Molecular Pharmacology Use of Positron Emission Tomography for Target Volume Definition
Current Radiopharmaceuticals